June 2020 Volume 16, Issue 6
![](https://cdn.drugdiscoverynews.com/assets/magazineIssueNo/189/iImg/37679/june-2020-cover-s.webp)
Volume 16, Issue 6 | June 2020
June 2020
In this Issue
Clinical Trials
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Well-tolerated tumor drug
Antibody therapeutic from Compugen demonstrates no dose-limiting toxicities![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Optimal OPTICs
ADVM-022 demonstrates efficacy, durability in OPTIC trial in wet AMD![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
More skin in the game
Libtayo shows promise for a second indication![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Usher update
ProQR offers upbeat interim analysis in Phase 1/2 trial of QR-421a for Usher Syndrome![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Investigating an IL-6 antibody
An update on Sanofi and Regeneron’s Kevzara trial in hospitalized COVID-19 patientsDiagnostics
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
A better test for COVID-19
Digital PCR solution cuts down on false negatives, may help in clinical trials![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Against antibiotic resistance
Selux Diagnostics receives additional 9.6 million for rapid AST platform![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Putting the ‘AI’ in diagnostics
A look at the growing trend of integrating artificial intelligence and machine learning with diagnosticsBusiness & Government Policy
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Broadening its footprint in biotech
Germany’s Sartorius acquires selected assets of Danaher Life Sciences![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
On the cutting edge
A roundup of instrumentation, software and other tools and technology news![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Q&A: The challenges of a vaccine for COVID-19
DDN takes some time to speak with Amélie Boulais, vaccine platform marketing manager at Sartorius Stedim BiotechResearch & Development
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Meaningful biomarkers
Precision medicine analyses show potential for Alzheimer’s drug![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
AUM launches Knockdown Coronavirus
RNA could be the kryptonite to defeat COVID-19![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Building a biobank
Biogen, Broad Institute and Partners HealthCare create consortium for COVID-19 efforts![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Timing is everything
Suppression of immune system may be key to reducing COVID-19 severityDiscovery
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Complementary cancer collaboration
Exscientia and SRI combine strengths for oncology drug discovery![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Relying on RNAi
Vir and Alnylam identify RNAi development candidate targeting SARS-CoV-2![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Arrakis partners with Roche
Collaboration will use RNA-targeted small-molecule discovery platform for multiple targets![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Further success in malaria initiative
Optibrium and Intellegens report in-vitro validation of in-silico-generated compound![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Know your enemy
Team uses knowledge of how SARS-CoV-2 infects cells to identify drugs that could combat it![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Managing macrolactones
New database could aid large-molecule drug discovery and researchContract Services
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
A strong complement in China
Reaction Biology, PharmaCore Labs strike up collaboration agreement![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Making a deal on ADCs
Trio Pharmaceuticals and Ajinomoto enter into development collaborationPreclinical
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Data recommend RECCE 327
Synthetic antibiotic shows efficacy against priority antibiotic-resistant pathogen![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
An autoimmune option
Immutep and Batavia Biosciences reach LAG-3 immunotherapy milestone![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Negative Data Prize is a positive?
Global Preclinical Data Forum says sharing negative science results is key to neuroscience progressFeature
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Focus Feature on Cancer Research News
Recent happenings on the R&D front to better understand cancer and create oncology therapeuticsCommentary
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Testing, testing, testing...1,2,3,4
Diagnostic testing is hotter news right now with COVID than perhaps ever before, but what does it all mean?![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Guest Commentary: Accelerating the pace of pharma innovation at a molecular level
Innovation isn’t just measured in the number of approvals, and looking at NMEs might be a better gauge of the ways in which drug discovery is currently thrivingSpecial Reports
![Drug Discovery News Placeholder Image](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/cards/image/placeholder-t.webp)
Special Report on Cancer: Anticipating antibodies
Digging deeper into repertoires means tapping into Plan B (cell)Editor's Focus
![Cancer, COVID](https://cdn.drugdiscoverynews.com/assets/articleNo/14323/aImg/37705/editor-s-focus-cancer-covid-and-change-t.webp)
Editor’s Focus: Cancer, COVID and change
Change is the name of the game in our understanding of cancer, the effect of COVID and the future of DDN magazine![](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/backgroundImages/pattern_left_sm_mobile.webp)
![Subscribe to Newsletter](https://cdn.drugdiscoverynews.com/statics/1.0.17/1737038092/public/assets/sections/newsletter/eNewsletter.webp)
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe